Supporting patient groups and continuously improving knowledge in our therapy areas is part of our corporate responsibility.
Our ultimate goal is to discover and develop innovative therapies to improve patients' quality of life.
We specialize in the treatment of life-threatening diseases. Our patients always come first.
Awards, Grants & Initiatives
New and exciting opportunities allow us to address previously unmet patient needs and these continue to drive us each day.
At CSL Behring, we work every day as if someone’s life depends on it, because it does.
CSL Behring's biotherapeutics are manufactured in state-of-the-art facilities under strictly controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
We want you to feel comfortable at CSL.
Get to know us and learn more about people, projects and what happens in the world of CSL Behring.
Information for the press, such as press releases and press contact.
Popular search terms:
CSL continues to provide medicines to patients around the world.
Inspiring network event for science and start-up scene in Marburg.
... and benefits for our patients and employees.
Awardees for 2022 have now been determined!
The regional initiative is committed to harmonizing economy, ecology and social issues.
500 Million IUs Coagulation Factor Replacement Therapy for the World Federation of Hemophilia Humanitarian Aid Program.
On Word Hemophilia Day we reaffirm our mission to create best-in-calss treatments for haemophilia
More than a century of scientific research and discovery
EMA Commences Review of Novel Gene Therapy Candidate Etranacogene Dezaparvovec for People with Hemophilia B
Americas
Asia Pacific
Middle East
Europe
